Anti‐helicobacter pylori activity of artemisia ludoviciana subsp. Mexicana and two of its bioactive components, estafiatin and eupatilin

Abstract

Artemisia ludoviciana subsp. mexicana, whose main etiological agent is Helicobacter pylori, has been traditionally used for the treatment of digestive ailments such as gastritis. In a previous screening study, the aqueous extract exhibited good in vitro anti‐H. pylori activity. With the aim of determining the efficacy of this species as a treatment for H. pylori related diseases and finding bio-active compounds, its aqueous extract was subjected to solvent partitioning and the fractions obtained were tested for their in vitro anti‐H. pylori effect, as well as for their in vivo gastroprotective and anti‐inflammatory activities. The aqueous extract showed a MIC = 250 μg/mL. No acute toxicity was induced in mice. A gastroprotection of 69.8 ± 3.8%, as well as anti‐inflammatory effects of 47.6 ± 12.4% and 38.8 ± 10.2% (by oral and topical administration, respectively), were attained. Estafiatin and eupatilin were isolated and exhibited anti‐H. pylori activity with MBCs of 15.6 and 31.2 μg/mL, respectively. The finding that A. ludoviciana aqueous extract has significant anti‐H. pylori, gastropro-tective and anti‐inflammatory activities is a relevant contribution to the ethnopharmacological knowledge of this species. This work is the first report about the in vivo gastroprotective activity of A. ludoviciana and the anti‐H. pylori activity of eupatilin and estafiatin.